Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1852
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission


This article has been cited by
1Plasminogen and angiostatin levels in female benign breast lesions
A. A. Tykhomyrov,I. L. Vovchuk,T. V. Grinenko
The Ukrainian Biochemical Journal.2015;87(5)103
2Glycosylation: a hallmark of cancer?
Bhairavi N. Vajaria,Prabhudas S. Patel
Glycoconjugate Journal.2017;34(2)147
3BRCC2 inhibits breast cancer cell growth and metastasis in vitro and in vivo via downregulating AKT pathway
X Li,X Kong,Y Wang,Q Yang
Cell Death & Disease.2013;4(8)e757
4Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation
Chia-Ming Yeh,Chiao-Wen Lin,Jia-Sin Yang,Wei-En Yang,Shih-Chi Su,Shun-Fa Yang
5Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer
Robert B. Bednarczyk,Neha Y. Tuli,Elyse K. Hanly,Ghada Ben Rahoma,Rachana Maniyar,Abraham Mittelman,Jan Geliebter,Raj K. Tiwari
6Clinical role of MiRNA 29a and MiRNA 335 on breast cancer management: their relevance to MMP2 protein level
Elham Ali Ahmed,Sohir A. Abd El-Basit,Mona A. Mohamed,Menha Swellam
Archives of Physiology and Biochemistry.2020;9(36)1
7Ilamycin C induces apoptosis and inhibits migration and invasion in triple-negative breast cancer by suppressing IL-6/STAT3 pathway
Qing Xie,Zhijie Yang,Xuanmei Huang,Zikang Zhang,Jiangbin Li,Jianhua Ju,Hua Zhang,Junying Ma
Journal of Hematology & Oncology.2019;12(1)1
8Body fluid MMP-2 as a putative biomarker in metastatic breast cancer
Oncology Letters.2012;3(3)699
9TGF-ß1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells
Luciana R Gomes,Letícia F Terra,Rosângela AM Wailemann,Leticia Labriola,Mari C Sogayar
BMC Cancer.2012;12(1)699
10TGF-ß1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells
Omer Bashir,Jian Cao,Stanley Zucker
BMC Cancer.2012;12(1)345
11Iridoid glycosides-Kutkin, Picroside I, and Kutkoside from Picrorrhiza kurroa Benth inhibits the invasion and migration of MCF-7 breast cancer cells through the down regulation of matrix metalloproteinases
Dharmender Rathee,Madhavi Thanki,Satish Bhuva,Sheetal Anandjiwala,Reena Agrawal
Arabian Journal of Chemistry.2013;6(1)49
12Recent Candidate Molecular Markers: Vitamin D Signaling and Apoptosis Specific Regulator of p53 (ASPP) in Breast Cancer
Jayendra B. Patel,Kinjal D. Patel,Shruti R. Patel,Franky D. Shah,Shilin N. Shukla,Prabhudas S. Patel
Asian Pacific Journal of Cancer Prevention.2012;13(5)1727
13Matrix metalloproteinases in Vietnamese patients with colorectal cancer
Thao Phuong Bui,Anh Ngoc Hoang,Phuong Lan Le,Bich Thi Pham,Linh Thi Tu Nguyen,Ha Minh Do,To Van Ta,Thai Hong Trinh
Oncology Letters.2017;13(4)2097
14Tissue Inhibitor of Metalloproteinase-2 Regulates Matrix Metalloproteinase-2–Mediated Endothelial Barrier Dysfunction and Breast Cancer Cell Transmigration through Lung Microvascular Endothelial Cells
Qiang Shen,Eugene S. Lee,Robert L. Pitts,Mack H. Wu,Sarah Y. Yuan
Molecular Cancer Research.2010;8(7)939
15Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene
Lisa Becks,Misty Prince,Hannah Burson,Christopher Christophe,Mason Broadway,Ken Itoh,Masayuki Yamamoto,Michael Mathis,Elysse Orchard,Runhua Shi,Jerry McLarty,Kevin Pruitt,Songlin Zhang,Heather E Kleiner-Hancock
BMC Cancer.2010;10(1)939
16MMP-9 expression in peripheral blood mononuclear cells and the association with clinicopathological features and prognosis of nasopharyngeal carcinoma
Jian-Rong He,Han Qin,Ze-Feng Ren,Cui Cui,Ying Zhang,Dharshana Ranatunga,Yi-Xin Zeng,Wei-Hua Jia
Clinical Chemistry and Laboratory Medicine.2011;49(4)939
17Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression
Kyle J. Isaacson,M. Martin Jensen,Nithya B. Subrahmanyam,Hamidreza Ghandehari
Journal of Controlled Release.2017;259(4)62
18Values of MMP-2 and MMP-9 in Tumor Tissue of Basal-Like Breast Cancer Patients
Sandra Radenkovic,Gordana Konjevic,Vladimir Jurisic,Katarina Karadzic,Marina Nikitovic,Kristina Gopcevic
Cell Biochemistry and Biophysics.2014;68(1)143
19Functional Characterization of Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) N- and C-Terminal Domains duringXenopus laevisDevelopment
M. A. Nieuwesteeg,J. A. Willson,M. Cepeda,M. A. Fox,S. Damjanovski
The Scientific World Journal.2014;2014(1)1
20Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
Eunhye Oh,Yoon-Jae Kim,Hyunsook An,Daeil Sung,Tae-Min Cho,Lee Farrand,Seojin Jang,Jae Hong Seo,Ji Young Kim
International Journal of Cancer.2018;143(8)1978
21RelB, a good prognosis predictor, links cell-cycle and migration to glioma tumorigenesis
Feng Shen,Qing Guo,Qi Hu,Ailiang Zeng,Weining Wu,Wei Yan,Yongping You
Oncology Letters.2018;143(8)1978
22Clinical relevance of cyclooxygenase-2 and matrix metalloproteinases (MMP-2 and MT1-MMP) in human breast cancer tissue
Mohammad A. Mohammad,Ahmed A. Zeeneldin,Zakaria Y. Abd Elmageed,Ebtsam H. Khalil,Said M. E. Mahdy,Hayat M. Sharada,Sabry K. Sharawy,Abdel-Hady A. Abdel-Wahab
Molecular and Cellular Biochemistry.2012;366(1-2)269
23Status of research on MMPs in India
Chinnadurai Saravanan,Sushil Kumar Singh
Expert Opinion on Therapeutic Targets.2011;15(6)715
24Status of research on MMPs in India
Irena Ranogajec
Expert Opinion on Therapeutic Targets.2017;15(6)3
25The roles of miRNAs in human breast cancer and canine mammary tumor
Richard Ming Chuan Yu,Yoke Kqueen Cheah
Applied Cancer Research.2017;37(1)3
26Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients
Irena Ranogajec,Jasminka Jakic-Razumovic,Velibor Puzovic,Jelka Gabrilovac
Medical Oncology.2012;29(2)561
27Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells
R S Price,D A Cavazos,R E De Angel,S D Hursting,L A deGraffenried
Prostate Cancer and Prostatic Diseases.2012;15(2)135
28GnRH-(1–5) activates matrix metallopeptidase-9 to release epidermal growth factor and promote cellular invasion
Madelaine Cho-Clark,Darwin O. Larco,Brian R. Zahn,Shaila K. Mani,T. John Wu
Molecular and Cellular Endocrinology.2015;415(2)114
29Acetyl glycyrrhetinic acid methyl ester as a promising glycyrrhizin derivative against the breast cancer cells (MCF-7)
MohamedG Ibrahim,FardousF El-Senduny,MagdyM Youssef,DiaaeldinM Elimam,FatmaM Abdel Bar,FaridA Badria
Journal of Reports in Pharmaceutical Sciences.2019;8(2)161
30Acetyl glycyrrhetinic acid methyl ester as a promising glycyrrhizin derivative against the breast cancer cells (MCF-7)
Sandra Radenkovic,Kristina Gopcevic,Gordana Konjevic,Vladimir Jurisic
Journal of Reports in Pharmaceutical Sciences.2017;8(2)3
31Two Faces of TGF-Beta1 in Breast Cancer
Joanna Magdalena Zarzynska
Mediators of Inflammation.2014;2014(2)1
32Matrix Metalloproteinases and Their Inhibitors: Correlation with Invasion and Metastasis in Oral Cancer
Ragini D. Singh,N. Haridas,Jayendra B. Patel,Franky D. Shah,Shilin N. Shukla,Pankaj M. Shah,Prabhudas S. Patel
Indian Journal of Clinical Biochemistry.2010;25(3)250
  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow